Home・Aandelen Lijst・SIGA Technologies Inc

SIGA Technologies Inc

Gesloten

SectorGezondheidszorg

3.12 -0.32

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.1

Max

3.15

Belangrijke statistieken
By Trading Economics
Inkomsten	-34M -3.5M
Verkoop	2.4M 6.2M
K/W Sectorgemiddelde	12.429 62.58
EPS	-0.048
Winstmarge	-55.334
Werknemers	49
EBITDA	5.6M -3.9M

Dividenden
By Acuity
Volgende Winsten	4 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-82M 250M
Vorige openingsprijs	3.44
Vorige sluitingsprijs	3.12

Nieuwssentiment

By Acuity

50%

152 / 340 Rangschikking in Healthcare

SIGA Technologies Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 jul 2026, 19:31 UTC

SIGA Technologies shares are higher amid a pullback in crude oil prices, easing inflation concerns, though the stock remains near its one-month range low.

23 jul 2026, 00:01 UTC

SIGA Technologies shares are higher in after-market trading, advancing notably since Wednesday's close, despite being below its 20-day moving average.

22 jul 2026, 23:01 UTC

SIGA Technologies Inc shares are higher in after-market trading, rising notably since Wednesday's close amid broader market concerns over oil prices and geopolitical tensions.

21 jul 2026, 17:21 UTC

SIGA Technologies Inc shares are higher today, amid positive market sentiment in Asia despite earlier downward movement and no specific company news identified.

20 jul 2026, 18:26 UTC

Shares of SIGA Technologies are higher during Monday's session, advancing since Friday's close amid broader market concerns over rising yields and inflation linked to oil prices.

Peer Vergelijking

Prijswijziging

SIGA Technologies Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan SIGA Technologies Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

152 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over SIGA Technologies Inc

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.